News
Media
Conference
Publication
CME/CE
Partners
Resources
Contribute
Subscribe
Clinical Forum Insights

Battling Against Resistant Pseudomonas Infections in the ICU

EP. 1: <i>Pseudomonas</i> Infections in the ICU: Who's Susceptible?

February 27th 2018

EP. 2: <i>Pseudomonas</i> Infections: Matching Causes and Prevention

February 27th 2018

EP. 3: <i>Pseudomonas</i> Infections in the ICU Versus on the Floor

February 27th 2018

EP. 4: <i>Pseudomonas</i> Infections: Nuancing the Use of Antibiotics

February 27th 2018

EP. 5: Fighting <i>Pseudomonas</i>: Impact On Patient Prognosis & Approaches to Combat Infection

February 27th 2018

EP. 6: Classes and Agents Available to Treat <i>Pseudomonas</i> Infections

February 27th 2018

EP. 7: <i>Pseudomonas</i> Infections Continue to Acquire Resistance, Complicating Treatment

February 27th 2018

EP. 8: Exploring Cephalosporin/β-Lactamase Inhibitor Combinations for Treatment of <i>Pseudomonas</i>

February 27th 2018

EP. 9: Exploring Appropriate Treatment Protocols for <i>Pseudomonas</i> Infections

February 27th 2018

EP. 10: Core Challenges in <i>Pseudomonas</i> Treatment Protocol

February 27th 2018

EP. 11: <i>Pseudomonas</i> Infections: Optimizing Diagnostic Strategies

February 27th 2018

EP. 12: Pseudomonas Infections: Selecting Upfront Antibiotics

February 27th 2018

EP. 13: <i>Pseudomonas</i> Infections: Secondary Approach to Treatment

February 27th 2018

EP. 14: Treating <i>Pseudomonas</i> Infections With Zerbaxa or Avycaz

February 27th 2018

EP. 15: Zerbaxa and Avycaz: Considerations for Treatment

February 27th 2018

EP. 16: The Future Treatment of Pseudomonas Infections

February 27th 2018

Trending on Contagion Live

Pritelivir Improves Outcomes in Immunocompromised Patients With Refractory Herpes Simplex Virus

Measles Update: February 6, 2026

PASTEUR Act Reintroduced in Congress

Antibiotics Deconstructed: IV Fosfomycin

HIV Spending for Fiscal Year 2026: The Latest Update